NCT07566377 Cord Blood Transplantation in Children and Young Adults With Blood Cancer Status RECRUITING Phase PHASE2
NCT07284927 Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies Status RECRUITING Phase PHASE1
NCT07260812 KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Status RECRUITING Phase PHASE1
NCT07259304 Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Status RECRUITING Phase N/A
NCT07254793 Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT Status NOT_YET_RECRUITING Phase PHASE1
NCT07249528 A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy Status RECRUITING Phase NA
NCT07195799 Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL Status RECRUITING Phase PHASE2
NCT07188558 A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy Status RECRUITING Phase PHASE3
NCT07188090 Mozobil for Autologous Hematopoietic Stem Cell Transplantation Status RECRUITING Phase PHASE2
NCT07020533 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant Status RECRUITING Phase PHASE1
NCT06939283 A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06915246 A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma Status RECRUITING Phase PHASE2
NCT06876662 A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma Status RECRUITING Phase PHASE4
NCT06876649 A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib Status RECRUITING Phase PHASE4
NCT06875063 GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL Status RECRUITING Phase PHASE1
NCT06720701 Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma. Status NOT_YET_RECRUITING Phase N/A